Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 EPA/DHA Omega-3 Products Market to Hit $35 Billion by 2016 - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

EPA/DHA Omega-3 Products Market to Hit $35 Billion by 2016

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

In a new report titled “The Global Market for EPA/DHA Omega-3 Products,” Packaged Facts has projected that global consumer spending on EPA/DHA fortified products will jump from $25.4 billion in 2011 to $34.7 billion in 2016, for a compound annual growth rate of 6.4%.
 
By geographic region, North America currently accounts for 43% of these consumer sales, but Asia-Pacific is projected to jump to a close second-place position by 2016.
 
These figures, based on research commissioned by the Global Organization for EPA and DHA Omega-3 (GOED) and presented at the GOED Exchange 2012 conference in Boston, cover six categories of packaged consumer products: infant formula; fortified foods and beverages; nutritional supplements; pharmaceuticals; clinical nutrition products; and pet food, treats and supplements.
 
Expanding public awareness of EPA/DHA omega-3 health benefits through media coverage of research findings, as well as developments in the regulatory environment, will spur continued growth in the global market for EPA/DHA omega-3 products.  According to David Sprinkle, publisher of Packaged Facts, other factors that will continue to create a positive growth environment for EPA/DHA omega-3 products include:
 

  • Consumer interest in functional food and fortified product line expansions;
  • Increasing demand for fortified infant formula due to population growth and rising middle class in emerging economies;
  • Continued popularity of EPA/DHA omega-3 nutritional supplement products, including krill oil and vegetarian algae-based supplements;
  • Introduction of pharmaceutical-grade products into South America and approval of generic pharmaceuticals in existing markets;
  • Expanding clinical nutrition market opportunities for disease- and disorder-specific formula applications, created through additional R & D and aggressive marketing by ingredient suppliers; and
  • Premiumization of pet foods due to humanization of companion animals.
 
For more information about this study, please click this link.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics